Exponent Inc (EXPO) Stock Price & Analysis
Exponent Inc (EXPO) fell 2.57% to USD 57.23 as of June 10, 2026 at 02:15 UTC, according to Nexqual real-time market data.
EXPO last closed at USD 58.74; the session ranged USD 56.89–60.42 on volume of 591,074 shares. Market capitalization is $2.78B, with a 52-week range of USD 51.91–81.95 (NMS). Source: Nexqual, June 10, 2026 at 02:15 UTC.
Key Statistics (as of June 10, 2026 at 02:15 UTC)
| Price | USD 57.23 |
|---|---|
| Change | ▼ 2.57% (down) |
| Previous Close | USD 58.74 |
| Open | USD 58.71 |
| Day Range | USD 56.89 – 60.42 |
| 52-Week Range | USD 51.91 – 81.95 |
| Volume | 591,074 shares |
| Market Cap | $2.78B |
| Exchange | NMS |
Technical Analysis (EXPO)
Nexqual's technical model rates EXPO "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:15 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 39.38 (neutral) |
| vs SMA50 | Below (USD 62.59) |
| MACD | -1.07 (negative) |
Analyst Ratings (EXPO)
Wall Street analysts rate EXPO "None" based on 3 analysts, with a mean price target of USD 81.67 (range USD 75–90), per Nexqual as of June 10, 2026 at 02:15 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 81.67 |
| High Target | USD 90 |
| Low Target | USD 75 |
| Buy / Hold / Sell | 3 / 1 / 0 |
Earnings (EXPO)
| Next Earnings Date | 2026-07-30 |
|---|---|
| EPS Estimate | USD 0.6 |
| Revenue Estimate | $147.49M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.59 vs est 0.61 ▼ miss |
| 2025-12-31 | USD 0.49 vs est 0.47 ▲ beat |
| 2025-09-30 | USD 0.55 vs est 0.53 ▲ beat |
| 2025-06-30 | USD 0.52 vs est 0.52 ▲ beat |
Source: Nexqual, June 10, 2026 at 02:15 UTC.
Financials & Fundamentals (EXPO)
| Total Revenue | $551.14M |
|---|---|
| Revenue Growth (YoY) | +10.50% |
| Gross Margin | +35.13% |
| Operating Margin | +27.26% |
| Profit Margin | +19.76% |
| ROE | +27.94% |
| Debt / Equity | 23.95 |
| Current Ratio | 2.4 |
| Total Cash | $118.55M |
| Total Debt | $81.04M |
| Free Cash Flow | $73.84M |
Source: Nexqual, June 10, 2026 at 02:15 UTC.
Financial Health Score (EXPO)
Nexqual rates Exponent Inc's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 02:15 UTC.
| Growth | Mixed — Revenue +3.5% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 35%, operating 27% |
| Balance Sheet | Strong — $119M cash vs $81M debt, net cash position |
| Cash Flow | Solid — FCF $74M, 14% margin |
| Efficiency | Strong — ROE 28%, ROA 10.1% |
Ownership (EXPO)
| Insider Ownership | +1.09% |
|---|---|
| Institutional Ownership | +101.72% |
| Shares Outstanding | 48.51M |
| Float | 47.93M |
| Short % of Float | +5.60% |
Source: Nexqual, June 10, 2026 at 02:15 UTC.
Leadership (EXPO)
Exponent Inc is led by Catherine Ford Corrigan P.E. (age 56), CEO & Director, per Nexqual as of June 10, 2026 at 02:15 UTC.
| CEO & Director | Catherine Ford Corrigan P.E. (age 56) |
|---|---|
| Group Vice President | Maureen T. F. Reitman F.S.P.E., P.E., Sc.D. (age 56) |
| Group Vice President | Joseph Rakow (age 48) |
| Group Vice President | Joseph Sala (age 48) |
| President | John D. Pye P.E. (age 54) |
Major Backers & Investors (EXPO)
Notable institutional backers of Exponent Inc include Kayne Anderson Rudnick Investment Management LLC, Conestoga Capital Advisors, LLC, Geneva Capital Management LLC, according to Nexqual as of June 10, 2026 at 02:15 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 8.01% |
| Conestoga Capital Advisors, LLC | 3.93% |
| Geneva Capital Management LLC | 3.7% |
| Royce & Associates LP | 2.36% |
| Two Sigma Investments, LP | 2.27% |
| First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers | 1.79% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 18.71% |
| BlackRock | 18.39% |
| State Street | 3.9% |
| Geode Capital | 3.4% |
Source: Nexqual, June 10, 2026 at 02:15 UTC.
From Exponent Inc's Latest SEC 10-K Filing (filed 2026-02-27)
Key Strengths & Strategy (as disclosed to the SEC)
- Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally.
- The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.
- It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering.
- The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FELE | Franklin Electric Co., Inc. | USD 102.63 | ▲ 4.13% |
| EXLS | ExlService Holdings, Inc. | USD 29.71 | ▲ 0.13% |
| AAON | AAON, Inc. | USD 129.66 | ▼ 2.23% |
| BCPC | Balchem Corporation | USD 162.32 | ▲ 1.51% |
| CRVL | CorVel Corp. | USD 61.11 | ▲ 2.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:15 UTC. This page is informational and not investment advice.